Front | Back |
Trough Level
|
The lowest concentration of drug reached in the body after it falls from it's peak level, usually measured in blood sample.
|
Trade Name
|
The commercial name given to a drug product by it's manufacturer; also called the proprietary name.
|
Toxicology
|
The study of poisions. It deals with effects of drugs and their detection and treatments to counteract their poisonous effects.
|
Toxicity
|
The condition of producing adverse bodily effects due to poisonous qualities.
|
Toxic
|
The quality of being poisonous.
|
Therapeutic Index
|
The ratio between the toxic therapeutic concentrations of a drug.
|
Therapeutic Effect
|
The desired or intended effect of a particular Medication.
|
Therapeutic Drug Monitoring
|
The process of measuring drug peak & trough levels to gauge the level of a pt. drug exposure & allow adjustments.
|
Synergistic Effect
|
Drug interaction where 2 drugs have a greater effect than, just the individual drug would.
|
Substrate
|
A substance (I.E. drug or natural biochemical in body) on which an enzyme acts.
|
Steady State
|
The physiologic state in which the amount of drug removed via elimination is equal to the amoun of the drug absorbed with each dose.
|
Receptor
|
A molecular structure within or on the outer surface of a cell.
|
Prodrug
|
An inactive drug dosage form that is converted to an active metabolite by varous biochemical reaction once it's inside the body.
|
Pharmacotherapeutics
|
The treatment of pathologic conditions through the use of drugs.
|
Pharmacology
|
Broadest term for the study or science of drugs.
|